Review



anti cd3 cd28 antibodies  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio X Cell anti cd3 cd28 antibodies
    Anti Cd3 Cd28 Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 303 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 antibodies/product/Bio X Cell
    Average 97 stars, based on 303 article reviews
    anti cd3 cd28 antibodies - by Bioz Stars, 2026-06
    97/100 stars

    Images



    Similar Products

    97
    Miltenyi Biotec miltenyi anti cd3 cd28 micro beads
    Miltenyi Anti Cd3 Cd28 Micro Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/miltenyi anti cd3 cd28 micro beads/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    miltenyi anti cd3 cd28 micro beads - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    97
    Bio X Cell anti cd3 cd28 antibodies
    Anti Cd3 Cd28 Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 antibodies/product/Bio X Cell
    Average 97 stars, based on 1 article reviews
    anti cd3 cd28 antibodies - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    86
    Fisher Scientific anti cd3 cd28 dynabeads
    Anti Cd3 Cd28 Dynabeads, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 dynabeads/product/Fisher Scientific
    Average 86 stars, based on 1 article reviews
    anti cd3 cd28 dynabeads - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    98
    Miltenyi Biotec cts dynabeads cd3 cd28
    Cts Dynabeads Cd3 Cd28, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cts dynabeads cd3 cd28/product/Miltenyi Biotec
    Average 98 stars, based on 1 article reviews
    cts dynabeads cd3 cd28 - by Bioz Stars, 2026-06
    98/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec anti cd3 cd28 macsibead particles
    Anti Cd3 Cd28 Macsibead Particles, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 macsibead particles/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    anti cd3 cd28 macsibead particles - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd3 cd28 beads
    Anti Cd3 Cd28 Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 beads/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    anti cd3 cd28 beads - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd3 cd28 expansion beads
    Anti Cd3 Cd28 Expansion Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 expansion beads/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    anti cd3 cd28 expansion beads - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    98
    Miltenyi Biotec dynabeads human t expander cd3 cd28
    a , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression. The cells were cultured in either serum free media (SF) or media supplemented with 10% fetal bovine serum (FBS) or human serum (HS) and GFP expression was measured by flow cytometry. Plotted values are GFP + cells relative to the SF value in each MOI condition in order to highlight changes in transduction efficiency when serum is present. Results are the mean ± SEM from three donors (n = 3). Significance was assessed using two-way ANOVA and Dunnett’s multiple comparisons test. b , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression at three different MOI. The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean from two donors (n = 2). c , Activated T cells from three donors were electroporated with an RNP targeting the TRAC locus and treated with either AAV6 or AAV-hT7 carrying an HDR template to knock in a CAR at TRAC . The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean ± SEM from three donors (n = 3). Significance was assessed using multiple two-tailed unpaired t -tests and the Holm-Šidák multiple comparisons test. d , TRAC -CAR-T cells expressing a 1928z-1XX were generated with a combination of EDV and AAV and functionally validated. TRAC -CAR-T cells were co-culture NALM6 cells at three effector cells to tumour cell ratios (E:T) for 24 h. Cytotoxicity was calculated by a luminescence read-out. Results are the mean ± SEM from four technical replicates (n = 4). e , Schematic of a genome-wide knockout screen to identify genes associated with AAV-hT7 uptake and processing in primary T cells. T cells were isolated from PBMCs, activated <t>with</t> <t>CD3/CD28</t> beads, and transduced with the lentiviral sgRNA library, followed by Cas9 electroporation (SLICE approach). 3 days later, T cells were re-activated for 48 h and transduced with AAV6 or AAV-hT7 expressing GFP. At 48 h after AAV-hT7 transduction cells were sorted into four bins based on GFP expression. Genomic DNA was extracted from cells in each bin, and amplicon libraries were prepared and sequenced to determine sgRNA enrichment. f , g , Volcano plot displaying genome-wide KO screen results for AAV6 ( f) and AAV-hT7 ( g ), p-values determined using MAGeCK RRA one-sided tests and methods. h , PBMC-humanized were injected with either AAV6 (n = 6) or AAV-hT7 (n = 6) carrying a ss-CAG-GFP cargo, or PBS (n = 3). DNA was isolated from different organs harvested one week after injection. Viral genomes were quantified through qPCR and normalized by the DNA input. Results are the mean ± SEM.
    Dynabeads Human T Expander Cd3 Cd28, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dynabeads human t expander cd3 cd28/product/Miltenyi Biotec
    Average 98 stars, based on 1 article reviews
    dynabeads human t expander cd3 cd28 - by Bioz Stars, 2026-06
    98/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd3 anti cd28 beads
    a , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression. The cells were cultured in either serum free media (SF) or media supplemented with 10% fetal bovine serum (FBS) or human serum (HS) and GFP expression was measured by flow cytometry. Plotted values are GFP + cells relative to the SF value in each MOI condition in order to highlight changes in transduction efficiency when serum is present. Results are the mean ± SEM from three donors (n = 3). Significance was assessed using two-way ANOVA and Dunnett’s multiple comparisons test. b , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression at three different MOI. The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean from two donors (n = 2). c , Activated T cells from three donors were electroporated with an RNP targeting the TRAC locus and treated with either AAV6 or AAV-hT7 carrying an HDR template to knock in a CAR at TRAC . The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean ± SEM from three donors (n = 3). Significance was assessed using multiple two-tailed unpaired t -tests and the Holm-Šidák multiple comparisons test. d , TRAC -CAR-T cells expressing a 1928z-1XX were generated with a combination of EDV and AAV and functionally validated. TRAC -CAR-T cells were co-culture NALM6 cells at three effector cells to tumour cell ratios (E:T) for 24 h. Cytotoxicity was calculated by a luminescence read-out. Results are the mean ± SEM from four technical replicates (n = 4). e , Schematic of a genome-wide knockout screen to identify genes associated with AAV-hT7 uptake and processing in primary T cells. T cells were isolated from PBMCs, activated <t>with</t> <t>CD3/CD28</t> beads, and transduced with the lentiviral sgRNA library, followed by Cas9 electroporation (SLICE approach). 3 days later, T cells were re-activated for 48 h and transduced with AAV6 or AAV-hT7 expressing GFP. At 48 h after AAV-hT7 transduction cells were sorted into four bins based on GFP expression. Genomic DNA was extracted from cells in each bin, and amplicon libraries were prepared and sequenced to determine sgRNA enrichment. f , g , Volcano plot displaying genome-wide KO screen results for AAV6 ( f) and AAV-hT7 ( g ), p-values determined using MAGeCK RRA one-sided tests and methods. h , PBMC-humanized were injected with either AAV6 (n = 6) or AAV-hT7 (n = 6) carrying a ss-CAG-GFP cargo, or PBS (n = 3). DNA was isolated from different organs harvested one week after injection. Viral genomes were quantified through qPCR and normalized by the DNA input. Results are the mean ± SEM.
    Anti Cd3 Anti Cd28 Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 anti cd28 beads/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    anti cd3 anti cd28 beads - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec anti cd3 cd28 cd2 magnetic beads
    a , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression. The cells were cultured in either serum free media (SF) or media supplemented with 10% fetal bovine serum (FBS) or human serum (HS) and GFP expression was measured by flow cytometry. Plotted values are GFP + cells relative to the SF value in each MOI condition in order to highlight changes in transduction efficiency when serum is present. Results are the mean ± SEM from three donors (n = 3). Significance was assessed using two-way ANOVA and Dunnett’s multiple comparisons test. b , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression at three different MOI. The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean from two donors (n = 2). c , Activated T cells from three donors were electroporated with an RNP targeting the TRAC locus and treated with either AAV6 or AAV-hT7 carrying an HDR template to knock in a CAR at TRAC . The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean ± SEM from three donors (n = 3). Significance was assessed using multiple two-tailed unpaired t -tests and the Holm-Šidák multiple comparisons test. d , TRAC -CAR-T cells expressing a 1928z-1XX were generated with a combination of EDV and AAV and functionally validated. TRAC -CAR-T cells were co-culture NALM6 cells at three effector cells to tumour cell ratios (E:T) for 24 h. Cytotoxicity was calculated by a luminescence read-out. Results are the mean ± SEM from four technical replicates (n = 4). e , Schematic of a genome-wide knockout screen to identify genes associated with AAV-hT7 uptake and processing in primary T cells. T cells were isolated from PBMCs, activated <t>with</t> <t>CD3/CD28</t> beads, and transduced with the lentiviral sgRNA library, followed by Cas9 electroporation (SLICE approach). 3 days later, T cells were re-activated for 48 h and transduced with AAV6 or AAV-hT7 expressing GFP. At 48 h after AAV-hT7 transduction cells were sorted into four bins based on GFP expression. Genomic DNA was extracted from cells in each bin, and amplicon libraries were prepared and sequenced to determine sgRNA enrichment. f , g , Volcano plot displaying genome-wide KO screen results for AAV6 ( f) and AAV-hT7 ( g ), p-values determined using MAGeCK RRA one-sided tests and methods. h , PBMC-humanized were injected with either AAV6 (n = 6) or AAV-hT7 (n = 6) carrying a ss-CAG-GFP cargo, or PBS (n = 3). DNA was isolated from different organs harvested one week after injection. Viral genomes were quantified through qPCR and normalized by the DNA input. Results are the mean ± SEM.
    Anti Cd3 Cd28 Cd2 Magnetic Beads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd3 cd28 cd2 magnetic beads/product/Miltenyi Biotec
    Average 97 stars, based on 1 article reviews
    anti cd3 cd28 cd2 magnetic beads - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    Image Search Results


    a , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression. The cells were cultured in either serum free media (SF) or media supplemented with 10% fetal bovine serum (FBS) or human serum (HS) and GFP expression was measured by flow cytometry. Plotted values are GFP + cells relative to the SF value in each MOI condition in order to highlight changes in transduction efficiency when serum is present. Results are the mean ± SEM from three donors (n = 3). Significance was assessed using two-way ANOVA and Dunnett’s multiple comparisons test. b , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression at three different MOI. The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean from two donors (n = 2). c , Activated T cells from three donors were electroporated with an RNP targeting the TRAC locus and treated with either AAV6 or AAV-hT7 carrying an HDR template to knock in a CAR at TRAC . The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean ± SEM from three donors (n = 3). Significance was assessed using multiple two-tailed unpaired t -tests and the Holm-Šidák multiple comparisons test. d , TRAC -CAR-T cells expressing a 1928z-1XX were generated with a combination of EDV and AAV and functionally validated. TRAC -CAR-T cells were co-culture NALM6 cells at three effector cells to tumour cell ratios (E:T) for 24 h. Cytotoxicity was calculated by a luminescence read-out. Results are the mean ± SEM from four technical replicates (n = 4). e , Schematic of a genome-wide knockout screen to identify genes associated with AAV-hT7 uptake and processing in primary T cells. T cells were isolated from PBMCs, activated with CD3/CD28 beads, and transduced with the lentiviral sgRNA library, followed by Cas9 electroporation (SLICE approach). 3 days later, T cells were re-activated for 48 h and transduced with AAV6 or AAV-hT7 expressing GFP. At 48 h after AAV-hT7 transduction cells were sorted into four bins based on GFP expression. Genomic DNA was extracted from cells in each bin, and amplicon libraries were prepared and sequenced to determine sgRNA enrichment. f , g , Volcano plot displaying genome-wide KO screen results for AAV6 ( f) and AAV-hT7 ( g ), p-values determined using MAGeCK RRA one-sided tests and methods. h , PBMC-humanized were injected with either AAV6 (n = 6) or AAV-hT7 (n = 6) carrying a ss-CAG-GFP cargo, or PBS (n = 3). DNA was isolated from different organs harvested one week after injection. Viral genomes were quantified through qPCR and normalized by the DNA input. Results are the mean ± SEM.

    Journal: Nature

    Article Title: In vivo site-specific engineering to reprogram T cells

    doi: 10.1038/s41586-026-10235-x

    Figure Lengend Snippet: a , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression. The cells were cultured in either serum free media (SF) or media supplemented with 10% fetal bovine serum (FBS) or human serum (HS) and GFP expression was measured by flow cytometry. Plotted values are GFP + cells relative to the SF value in each MOI condition in order to highlight changes in transduction efficiency when serum is present. Results are the mean ± SEM from three donors (n = 3). Significance was assessed using two-way ANOVA and Dunnett’s multiple comparisons test. b , Activated T cells were treated with either AAV6 or AAV-hT7 carrying a GFP transcript for transient expression at three different MOI. The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean from two donors (n = 2). c , Activated T cells from three donors were electroporated with an RNP targeting the TRAC locus and treated with either AAV6 or AAV-hT7 carrying an HDR template to knock in a CAR at TRAC . The cells were cultured in either serum free media. These values are used to calculate the relative GFP expression in (Fig. ). Results are the mean ± SEM from three donors (n = 3). Significance was assessed using multiple two-tailed unpaired t -tests and the Holm-Šidák multiple comparisons test. d , TRAC -CAR-T cells expressing a 1928z-1XX were generated with a combination of EDV and AAV and functionally validated. TRAC -CAR-T cells were co-culture NALM6 cells at three effector cells to tumour cell ratios (E:T) for 24 h. Cytotoxicity was calculated by a luminescence read-out. Results are the mean ± SEM from four technical replicates (n = 4). e , Schematic of a genome-wide knockout screen to identify genes associated with AAV-hT7 uptake and processing in primary T cells. T cells were isolated from PBMCs, activated with CD3/CD28 beads, and transduced with the lentiviral sgRNA library, followed by Cas9 electroporation (SLICE approach). 3 days later, T cells were re-activated for 48 h and transduced with AAV6 or AAV-hT7 expressing GFP. At 48 h after AAV-hT7 transduction cells were sorted into four bins based on GFP expression. Genomic DNA was extracted from cells in each bin, and amplicon libraries were prepared and sequenced to determine sgRNA enrichment. f , g , Volcano plot displaying genome-wide KO screen results for AAV6 ( f) and AAV-hT7 ( g ), p-values determined using MAGeCK RRA one-sided tests and methods. h , PBMC-humanized were injected with either AAV6 (n = 6) or AAV-hT7 (n = 6) carrying a ss-CAG-GFP cargo, or PBS (n = 3). DNA was isolated from different organs harvested one week after injection. Viral genomes were quantified through qPCR and normalized by the DNA input. Results are the mean ± SEM.

    Article Snippet: After thawing, T lymphocytes were purified using the EasySep Human T cell isolation kit (StemCell Technologies, 17951) and activated with Dynabeads Human T Expander CD3/CD28 at a 1:1 bead-to-cell ratio (Gibco, 11141D) in X-VIVO 15 medium (Lonza, BP04-744Q) supplemented with human serum (5%, Gemini Bioproducts, 100-512), IL-7 (5 ng ml −1 , Miltenyi Biotec, 130-095-367) and IL-15 (5 ng ml −1 , Miltenyi Biotec, 130-095-760) at a density of 1 × 10 6 cells per ml.

    Techniques: Expressing, Cell Culture, Flow Cytometry, Transduction, Knock-In, Two Tailed Test, Generated, Co-Culture Assay, Genome Wide, Knock-Out, Isolation, Electroporation, Amplification, Injection